News

Medtronic, CoreValve, Japan, approval, trial

Medtronic announced Japanese regulatory approval for the self-expanding transcatheter CoreValve system for patients with severe aortic stenosis (AS). Japanese regulatory authorities granted...

Corevalve, VIV, valve in valve, FDA

The U.S. Food and Drug Administration (FDA) expanded the approved use of the CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system to treat certain patients who have...

Edwards Lifesciences Corp. announced that chairman and CEO Michael A. Mussallem served as an invited expert panelist on behalf of the Advanced Medical Technology Association (AdvaMed) at the...

TAVR, transcatheter heart valves, GlobalData, TMVR

Research and consulting firm GlobalData reported that the global market value for transcatheter heart valves will expand at a Compound Annual Growth Rate (CAGR) of 19.7 percent through 2020,...

congenital heart disease, CHD, tPVR, consensus paper, minimally invasive

A new expert consensus paper released by a coalition of cardiovascular organizations provides guidance on transcatheter pulmonic valve replacement (tPVR) for children and adults who were...

Edwards Lifesciences, Sapien 3, Partner, ACC.15, acc 2015

he Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak rates than earlier generation devices in patients at high risk for surgery and showed...

Mitralign, transcatheter triscupid repair, TTVR, TR, first in human

A detailed reporting of the first successful case of a direct transcatheter tricuspid repair (TTVR) for severe TR has been reported by Prof. J. Schofer, M.D., of the Medicare Center and Department...

Mitraclip, abbott, mitral valve repair, ACC, transcatheter mitral valve repair

The commercial track record with transcatheter mitral valve repair, approved for patients at high risk for surgery, compares favorably with pre-approval reports, according to findings from a U.S....

TriGuard, Keystone, embolic protection, TAVR

March 19, 2015 — An investigational device that deflects debris away from the brain during transcatheter aortic valve replacement (TAVR) seems to improve in-hospital safety outcomes and cognitive...

CTSN, atrial fibrillation, surgical ablation, mitral valve surgery

New study results from The Cardiothoracic Surgical Trials Network (CTSN) show the addition of surgical ablation during mitral valve surgery reduces the occurrence of atrial fibrillation in...

Sterne Agee, ACC, Medtronic, Edwards, St. Jude, TAVR, heart failure

The American College of Cardiology (ACC) hosted its 64th Annual Scientific Session & Expo over the weekend in San Diego, California. Key data from multiple transcatheter aortic valve...

CoreValve, high risk study, TAVR, Medtronic, ACC

Medtronic plc unveiled new two-year data from the CoreValve U.S. Pivotal High Risk Study, which demonstrated superior two-year survival benefits from transcatheter aortic valve replacement (TAVR)...

Edwards, Sapien, PARTNER trial, five-year outcomes, ACC

Five-year data suggest that the Sapien transcatheter heart valve (Edwards Lifesciences) is a feasible option for patients with severe aortic stenosis deemed to be at high risk for open-heart...

TAVR, TAVI, acc, ACC.15, corevalve

Key data from many transcatheter aortic valve replacement (TAVR) clinical trials will be presented as late-breakers at the American College of Cardiology (ACC) Scientific Session this weekend,...

TAVR, study, one-year outcomes, heart valve repair, JAMA, Mayo Clinic

In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve replacement (TAVR), death rate after one year was nearly one in four, according to a study in the March...

Four-month-old Jackson Lane has a large scar that looks like a giant zipper down the center of his chest, the result of undergoing a lifesaving surgical procedure at just five days old to repair...

TMVR, Europe, heart valve repair, GlobalData

In light of a recent American Heart Association report stating that U.S. mitral valve regurgitation prevalence was 1.7 percent in 2014, a significant opportunity exists for development of an...

Pie Medical Imaging, CAAS A-Valve, qRA, angiography, heart valve repair

Pie Medical Imaging BV announced that it received 510(k) clearance from the U.S. Food and Drug Administration for its CAAS A-Valve product including the quantitative Regurgitation Analysis (qRA)...

TAVR, Henry Ford Hospital, O'Neill, Greenbaum

Transcatheter aortic valve replacement (TAVR) is not only a breakthough minimally invasive medical therapy, but offers a new business opportunity for hospitals that begin a program. The technology...

Here are my predictions for technologies to watch in the coming year that have the potential to fundamentally change the practice of cardiology: